Firefly Neuroscience, Inc. (NASDAQ:AIFF) Shares Shorted: Short Interest Up 265.0% in September

Firefly Neuroscience, Inc. (NASDAQ:AIFF) was the target of a large increase in short interest in September. As of September 30th, there was short interest totaling 1,098,284 shares, an increase of 265.0% from the September 15th total of 300,863 shares. Approximately 7.5% of the shares of the company are sold short. Based on an average daily trading volume, of 14,576,030 shares, the short-interest ratio is currently 0.1 days.

Institutional Investors Weigh In On Firefly Neuroscience

An institutional investor recently bought a new position in Firefly Neuroscience stock. BlackRock Inc. acquired a new position in shares of Firefly Neuroscience, Inc. (NASDAQ:AIFF) in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 187,168 shares of the company’s stock, valued at approximately $226,000. BlackRock Inc. owned about 1.20% of Firefly Neuroscience as of its most recent filing with the Securities & Exchange Commission. 4.96% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

AIFF has been the topic of a number of analyst reports. Weiss Ratings restated a “sell (d-)” rating on shares of Firefly Neuroscience in a research note on Friday, August 14th. Wall Street Zen cut Firefly Neuroscience from a “hold” rating to a “sell” rating in a research report on Saturday, August 15th. One analyst has rated the stock with a Sell rating. According to data from MarketBeat, the company currently has a consensus rating of “Sell”.

Firefly Neuroscience Stock Performance

AIFF stock traded down $0.04 during trading on Monday, reaching $1.15. 50,318 shares of the company were exchanged, compared to its average volume of 4,290,916. The company has a market cap of $17.98 million, a P/E ratio of -1.94 and a beta of 0.51. Firefly Neuroscience has a 52-week low of $0.62 and a 52-week high of $3.15. The stock’s 50 day moving average price is $1.19 and its 200 day moving average price is $1.46.

Firefly Neuroscience (NASDAQ:AIFF) last issued its earnings results on Monday, August 10th. The company reported ($0.10) earnings per share for the quarter. Firefly Neuroscience had a negative return on equity of 90.17% and a negative net margin of 506.23%. The company had revenue of $0.51 million for the quarter.

Firefly Neuroscience Company Profile

Firefly Neuroscience, Inc is a medical technology company focused on applying artificial intelligence to brain health and cognitive assessment. Its principal product is the Brain Network Analytics (BNA) platform, which analyzes electroencephalogram (EEG) data to generate insights into brain function and cognitive performance.

The BNA platform is designed to support clinicians, researchers and pharmaceutical companies in evaluating cognitive impairment and monitoring changes in brain health.